Speaker illustration

Associate Professor Saga Johansson

Molndal (Sweden)

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session: Clinical platelet studies

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb